Erdafitinib is a small-molecule chemical compound identified by CAS No. 1346242-81-6. Its molecular formula is C25H30N6O2. The compound is known for inhibiting certain fibroblast growth factor receptors, or FGFRs, which are involved in cellular signaling and the regulation of biological processes.
FGFR proteins help cells respond to growth-related signals. Researchers study these pathways to understand how changes in receptor activity may influence cellular behavior. Erdafitinib has an established role in FGFR-targeted cancer treatment and is also discussed in scientific literature concerning receptor inhibition.
For purchasers, the first step is to establish whether the offered material matches the required chemical identity and technical specifications. The product information supplied for this listing describes a powder with a stated purity above 99%, with HPLC-UV identified as the analytical method. Batch-specific documentation should be reviewed before the material is selected for a particular purpose.
| Specification | Details |
|---|---|
| Product Name | Erdafitinib |
| CAS No. | 1346242-81-6 |
| Molecular Formula | C25H30N6O2 |
| EINECS No. | 807-395-6 |
| Product Type | Synthesis Material Intermediate |
| Grade | Technical, as specified |
| Appearance | Powder |
| Color | White, subject to batch confirmation |
| Stated Purity | Greater than 99% |
| Test Method | HPLC-UV |
| Origin | China |
| Package Options | 1 g, 100 g, 1 kg, 25 kg, subject to availability |
| Customized Packaging | Available upon confirmation |
| Sample | Subject to availability |
| Estimated Delivery Time | 5–10 days, subject to order confirmation |
| Shipping Method | Air or sea, subject to destination and regulations |
| Storage | Follow the verified product-specific instructions |
| Retest Period | Confirm using supporting stability documentation |
A CAS number provides a standardized reference for identifying a chemical substance. For Erdafitinib, the listed number is 1346242-81-6. The molecular formula provides additional information about its chemical composition.
When comparing suppliers, check that the product name, CAS number, and molecular formula are consistent across the quotation, label, and technical documents. These checks help reduce confusion when purchasing materials with similar names or related chemical structures.
The stated purity for this product is greater than 99%. Buyers should request the relevant certificate of analysis (COA) to check the actual batch result and the analytical information supporting it.
HPLC-UV stands for high-performance liquid chromatography with ultraviolet detection. The method separates components in a sample and measures suitable compounds through their ultraviolet absorption. The reported results depend on the analytical procedure and its acceptance criteria.
Purity alone does not describe every aspect of material quality. Depending on the intended application, other characteristics may need to be assessed separately. Buyers should therefore compare the available documentation with their own technical requirements.
The product is described as a powder. The original specification identifies its color as white, although the actual appearance should be confirmed against the current batch information.
Visual inspection can help identify obvious differences in appearance, but it cannot establish chemical identity or purity. Appropriate testing and documentation remain necessary for a meaningful quality assessment.
![]()
Erdafitinib is associated with FGFR inhibition. These receptors form part of signaling systems that influence how cells receive and respond to biological signals.
Research into FGFR pathways helps scientists investigate receptor activity and related molecular mechanisms. Erdafitinib's established pharmacological background makes it relevant to scientific discussions of FGFR-targeted approaches.
The suitability of a particular material depends on its verified grade, purity, supporting documents, and the requirements of the intended project. A technical-grade product should not automatically be considered suitable for pharmaceutical manufacturing, clinical studies, or human administration.
This page provides general chemical and sourcing information rather than medical advice or a guarantee of suitability for a particular application.
The listed package sizes range from 1 g to 25 kg. Actual options depend on availability, order quantity, and packaging suitability. Buyers should confirm the requested format before placing an order.
The original product information specifies storage at 2–8°C, protected from light and kept sealed. These conditions should be verified using the applicable technical documentation rather than assumed to apply to every supplied batch.
Follow the product-specific safety data sheet (SDS) when handling the material. Use appropriate protective equipment, avoid unnecessary exposure to powder, and keep the container properly closed and labeled.
The two-year retest period in the supplied data should only be stated as confirmed when supported by relevant stability information.
To help confirm availability, buyers should provide the requested quantity, package size, destination country, and documentation requirements. This information supports a more accurate review of packaging and delivery arrangements.
The estimated lead time is 5–10 days, subject to confirmation. Air or sea shipping may be considered according to the destination, carrier acceptance, and applicable customs and transport requirements.
For customized orders, confirm the final specifications, quotation, and expected dispatch schedule before proceeding. Sample availability should also be checked in advance.
![]()
What is the CAS number of Erdafitinib?
The listed CAS number is 1346242-81-6.
What is the molecular formula?
Erdafitinib has the molecular formula C25H30N6O2.
What purity is specified?
The supplied specification states greater than 99% purity. Check the relevant COA for the actual batch result.
Which test method is listed?
HPLC-UV is the analytical method specified in the product information.
What packaging formats are available?
Listed formats include 1 g, 100 g, 1 kg, and 25 kg, subject to confirmation.
How can I request a quotation?
Provide the quantity, preferred packaging, destination, and required documents so that product availability and delivery arrangements can be reviewed.
Erdafitinib CAS 1346242-81-6 is a small-molecule compound associated with FGFR inhibition. The supplied specifications identify its molecular formula as C25H30N6O2 and describe a powder with a stated purity above 99%, using HPLC-UV as the listed analytical method.
Before purchasing, verify the batch documentation, applicable storage instructions, packaging availability, and suitability for the intended use.